Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Ines Kristensen a Bandim Health Project, Apartado 861, Bissau,
Guinea-Bissau, b Danish Epidemiology Science
Centre, Statens Serum Institut, Copenhagen, Denmark
Correspondence to: P Aaby,
Department of Epidemiology Research, Statens Serum Institut,
Artillerivej 5, 2300 Copenhagen S, Denmark psb{at}sol.gtelecom.gw
Objective:
To examine the association between routine childhood vaccinations and survival among infants in Guinea-Bissau.
Design:
Follow up study.
Participants:
15 351 women and their children born
during 1990 and 1996.
Setting:
Rural Guinea-Bissau.
Main outcome measures:
Infant mortality over six
months (between age 0-6 months and 7-13 months for BCG, diphtheria,
tetanus, and pertussis, and polio vaccines and between 7-13 months and
14-20 months for measles vaccine).
Results:
Mortality was lower in the group vaccinated with any vaccine compared with those not vaccinated, the mortality ratio being 0.74 (95% confidence interval 0.53 to 1.03). After cluster, age, and other vaccines were adjusted for, BCG was associated with significantly lower mortality (0.55 (0.36 to 0.85)). However, recipients of one dose of diphtheria, tetanus, and pertussis or polio
vaccines had higher mortality than children who had received none of
these vaccines (1.84 (1.10 to 3.10) for diphtheria, tetanus, and
pertussis). Recipients of measles vaccine had a mortality ratio of 0.48 (0.27 to 0.87). When deaths from measles were excluded from the
analysis the mortality ratio was 0.51 (0.28 to 0.95). Estimates were
unchanged by controls for background factors.
Conclusions:
These trends are unlikely to be explained exclusively by selection biases since different vaccines were associated with opposite tendencies. Measles and BCG vaccines may have
beneficial effects in addition to protection against measles and tuberculosis.
Read all Rapid Responses